MeVis Medical Solutions AG (M3V.DE)
EUR 24.6
(0.0%)
EUR 24.6
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 558.96 Thousand EUR | 2.98% |
| 2022 | 11.64 Million EUR | 8.33% |
| 2021 | 10.75 Million EUR | 1.09% |
| 2020 | 10.63 Million EUR | 1.52% |
| 2019 | 10.47 Million EUR | 11.98% |
| 2018 | 9.35 Million EUR | -6.49% |
| 2017 | 10 Million EUR | 93.31% |
| 2016 | 5.17 Million EUR | -51.13% |
| 2015 | 10.58 Million EUR | 24.17% |
| 2014 | 8.52 Million EUR | -13.57% |
| 2013 | 9.86 Million EUR | 0.66% |
| 2012 | 9.8 Million EUR | -32.91% |
| 2011 | 14.6 Million EUR | -25.92% |
| 2010 | 19.71 Million EUR | 67.43% |
| 2009 | 11.77 Million EUR | 20.03% |
| 2008 | 9.81 Million EUR | 45.45% |
| 2007 | 6.74 Million EUR | 112.54% |
| 2006 | 3.17 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 129.5 Thousand EUR | -80.93% |
| 2024 Q1 | 679.25 Thousand EUR | 661.78% |
| 2023 Q1 | 1.12 Million EUR | 1912.05% |
| 2023 FY | 11.99 Million EUR | 2.98% |
| 2023 Q4 | 89.16 Thousand EUR | 0.0% |
| 2023 Q3 | 89.16 Thousand EUR | -92.1% |
| 2023 Q2 | 1.12 Million EUR | 0.0% |
| 2022 Q3 | 56.06 Thousand EUR | -94.14% |
| 2022 FY | 11.64 Million EUR | 8.33% |
| 2022 Q4 | 56.06 Thousand EUR | 0.0% |
| 2022 Q1 | 302.52 Thousand EUR | -77.55% |
| 2022 Q2 | 957.04 Thousand EUR | 216.35% |
| 2021 Q1 | 626.52 Thousand EUR | -41.72% |
| 2021 FY | 10.75 Million EUR | 1.09% |
| 2021 Q4 | 1.34 Million EUR | 124.35% |
| 2021 Q3 | 600.67 Thousand EUR | 29.11% |
| 2021 Q2 | 465.23 Thousand EUR | -25.74% |
| 2020 FY | 10.63 Million EUR | 1.52% |
| 2020 Q1 | 537.45 Thousand EUR | -84.96% |
| 2020 Q2 | 1.05 Million EUR | 96.72% |
| 2020 Q3 | 690.25 Thousand EUR | -34.71% |
| 2020 Q4 | 1.07 Million EUR | 55.76% |
| 2019 Q4 | 3.57 Million EUR | 40.65% |
| 2019 FY | 10.47 Million EUR | 11.98% |
| 2019 Q3 | 2.54 Million EUR | 14.25% |
| 2019 Q2 | 2.22 Million EUR | 4.12% |
| 2019 Q1 | 2.13 Million EUR | 5.64% |
| 2018 Q3 | 2.47 Million EUR | -6.24% |
| 2018 Q2 | 2.64 Million EUR | 18.19% |
| 2018 Q1 | 2.23 Million EUR | 38.26% |
| 2018 FY | 9.35 Million EUR | -6.49% |
| 2018 Q4 | 2.02 Million EUR | -18.43% |
| 2017 Q1 | 2.45 Million EUR | 169.23% |
| 2017 Q3 | 2.64 Million EUR | -20.62% |
| 2017 Q4 | 1.61 Million EUR | -38.74% |
| 2017 Q2 | 3.32 Million EUR | 35.8% |
| 2017 FY | 10 Million EUR | 93.31% |
| 2016 Q4 | 909.99 Thousand EUR | -64.59% |
| 2016 Q1 | 2.64 Million EUR | -0.53% |
| 2016 FY | 5.17 Million EUR | -51.13% |
| 2016 Q3 | 2.57 Million EUR | -0.27% |
| 2016 Q2 | 2.57 Million EUR | -2.64% |
| 2015 FY | 10.58 Million EUR | 24.17% |
| 2015 Q4 | 2.66 Million EUR | 4.89% |
| 2015 Q3 | 2.53 Million EUR | -8.18% |
| 2015 Q2 | 2.76 Million EUR | 8.95% |
| 2015 Q1 | 2.53 Million EUR | 21.22% |
| 2014 Q4 | 2.09 Million EUR | 8.34% |
| 2014 Q3 | 1.93 Million EUR | -2.87% |
| 2014 Q2 | 1.98 Million EUR | -20.83% |
| 2014 Q1 | 2.51 Million EUR | -0.59% |
| 2014 FY | 8.52 Million EUR | -13.57% |
| 2013 Q2 | 2.42 Million EUR | 22.22% |
| 2013 Q1 | 1.98 Million EUR | -16.53% |
| 2013 FY | 9.86 Million EUR | 0.66% |
| 2013 Q3 | 2.42 Million EUR | 0.37% |
| 2013 Q4 | 2.52 Million EUR | 3.99% |
| 2012 Q3 | 2.49 Million EUR | -15.59% |
| 2012 Q4 | 2.37 Million EUR | -4.74% |
| 2012 Q2 | 2.95 Million EUR | -45.18% |
| 2012 FY | 9.8 Million EUR | -32.91% |
| 2012 Q1 | 5.38 Million EUR | 90.28% |
| 2011 Q3 | 3.23 Million EUR | 2.21% |
| 2011 Q1 | 10.05 Million EUR | 262.4% |
| 2011 FY | 14.6 Million EUR | -25.92% |
| 2011 Q2 | 3.16 Million EUR | -68.53% |
| 2011 Q4 | 2.82 Million EUR | -12.55% |
| 2010 Q1 | 2.65 Million EUR | -24.73% |
| 2010 Q2 | 3.96 Million EUR | 49.57% |
| 2010 Q3 | 3.42 Million EUR | -13.54% |
| 2010 FY | 19.71 Million EUR | 67.43% |
| 2010 Q4 | 2.77 Million EUR | -19.08% |
| 2009 Q4 | 3.52 Million EUR | 30.98% |
| 2009 Q2 | 3.65 Million EUR | 0.0% |
| 2009 FY | 11.77 Million EUR | 20.03% |
| 2009 Q3 | 2.68 Million EUR | -26.35% |
| 2008 Q3 | 2.49 Million EUR | 0.0% |
| 2008 FY | 9.81 Million EUR | 45.45% |
| 2007 FY | 6.74 Million EUR | 112.54% |
| 2006 FY | 3.17 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| DocCheck AG | 9.43 Million EUR | 94.073% |
| CompuGroup Medical SE & Co. KGaA | 143.68 Million EUR | 99.611% |
| Nexus AG | 44.98 Million EUR | 98.757% |